Anti-cd38 antibody formulations and uses thereof

Patent Number: CL-2023002084-A1

Publication Year: 2024

Application Year: 2023

Priority Year: 2023

Jurisdictions: CL

Status: N/A

Inventors:

JACOB D CLAUSEN RICHARD HIBBERT MICHAEL B DALGAARD

Applicants:

  1. Genmab (Denmark)
    2. [NORA names: Genmab; Private Research; Denmark; Europe, EU; Nordic; OECD]

Abstract

Pharmaceutical formulations comprising antibodies that bind CD38 and the use of said formulations in the treatment of cancer and other indications.

Patent Family Records (1)

Anti-cd38 antibody formulations and uses thereof

GENMAB AS, Genmab (Denmark) JACOB D CLAUSEN, RICHARD HIBBERT, MICHAEL B DALGAARD

2024, CL-2023002084-A1

Data Provider: Digital Science

LINKS
+

External Systems

SUBJECTS
+

PATENT CATEGORIES
+

IPCR Classification

CPC Classification

[No Data Available]

METRICS
+

Citation Metrics

Times Cited in Patents: 0external link

References to Patents: [No Data Available]

References to Publications: 0external link